Siticolin P

Siticolin P is a combination nootropic tablet developed by Cytech Pharma, containing 500 mg of citicoline and 400 mg of piracetam. Citicoline acts as a metabolic precursor for phosphatidylcholine, supporting the synthesis and repair of neuronal membranes and enhancing neurotransmitter production. Piracetam is a cyclic derivative of GABA that exerts various neuromodulatory effects, including the improvement of membrane fluidity and the modulation of neurotransmission. The oral formulation is primarily indicated for the management of cognitive impairment, neurocognitive support, and recovery following an ischemic stroke. As a branded generic product, it leverages the complementary pathways of its components to support brain health through membrane repair and neurotransmitter synthesis modulation.

Brand names

Siticolin P

Other names

citicoline + piracetam